GlassScriptPhysician profile
Amy Jo King
NPI 1821737719
$6,722.49
in general payments reported to CMS, 2019-2025
33 companies · $1,489 in 2025
The $1,489 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $587 · 2023: $1,374 · 2024: $3,272 · 2025: $1,489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,401 · Travel and Lodging: $1,125 · Education: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,401.43 |
| Travel and Lodging | $1,124.75 |
| Education | $608.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,953.30 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $630.65 | 2022-2025 | Fasenra, Airsupra, Tezspire |
| Sanofi-Aventis U.S. LLC | $377.47 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $374.45 | 2022-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Grifols USA, LLC | $329.36 | 2022-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $281.13 | 2022-2024 | Wakix |
| Jazz Pharmaceuticals INC. | $275.06 | 2022-2025 | |
| Genzyme Corporation | $206.89 | 2022-2025 | |
| Amgen INC. | $204.45 | 2023-2025 | Tezspire, Blincyto, Kyprolis |
| Astellas Pharma US INC | $179.90 | 2023-2024 | Cresemba |
| United Therapeutics Corporation | $98.60 | 2022-2025 | Orenitram, Remodulin |
| Regeneron Healthcare Solutions, INC. | $82.49 | 2023-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $77.86 | 2022-2025 | Opsumit, Uptravi |
| Axsome Therapeutics, INC. | $69.35 | 2023-2024 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $54.55 | 2023-2025 | Glassia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $48.16 | 2025 | |
| Electromed, INC. | $47.10 | 2022-2025 | Smartvest |
| Glaxosmithkline, LLC. | $46.14 | 2024-2025 | Nucala |
| Baxter Healthcare | $43.72 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $36.71 | 2025 | Ohtuvayre |
| Tactile Systems Technology INC | $35.07 | 2025 | Nimbl, Flexitouch Plus |
| Abbvie INC. | $32.37 | 2023-2024 | |
| Philips North America LLC | $30.12 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Genentech, INC. | $29.98 | 2025 | Gazyva |
| Insmed, INC. | $29.00 | 2024-2025 | Brinsupri, Arikayce |
| Avadel Cns Pharmaceuticals, LLC | $27.78 | 2023-2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $25.53 | 2022 | |
| Sanofi Pasteur INC. | $20.07 | 2023 | |
| Hospira, INC. | $17.57 | 2024 | |
| Lilly USA, LLC | $14.98 | 2025 | Zepbound |
| Azurity Pharmaceuticals, INC. | $14.90 | 2024 | Horizant |
| Pfizer INC. | $13.96 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.